Genticel Company

Gentiel develops therapeutic vaccines for the prevention of cervical cancer in HPV infected women.

Investors

Headquarters: Paris, Ile-de-France, France
Funding Status: M&A
Founded Date: 2001-01-01
Last Funding Type: Series D
Last Funding Date: 2013-04-24
Total Funding: $41 382 652
Industry: Longevity
Register and Claim Ownership